Accepted for Publication: July 12, 2013.
Published Online: November 27, 2013. doi:10.1001/jamadermatol.2013.7165.
Study concept and design: Minocha, West, Ghovanloo, Laumann.
Acquisition of data: Minocha, Holbrook, Ghovanloo, Laumann.
Analysis and interpretation of data: All authors.
Drafting of the manuscript: Minocha, Holbrook, Laumann.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Minocha.
Obtained funding: Minocha, Ghovanloo, Laumann.
Administrative, technical, or material support: All authors.
Study supervision: Ghovanloo, Laumann.
Conflict of Interest Disclosures: Dr Ghovanloo is cofounder of Bionic Sciences, Inc, a start-up company that has licensed TDS technology from Georgia Institute of Technology. No other disclosures are reported.
Funding/Support: This work was supported in part by National Institute of Biomedical Imaging and Bioengineering grant 1RC1EB010915. Dr Minocha received salary support through a Medical-Dermatology grant from the National Psoriasis Foundation.
Role of the Sponsors: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; or in the preparation, review, or approval of the manuscript.
Trial Registration: clinicaltrials.gov Identifier: NCT01124292.
Additional Information: The US Food and Drug Administration determined that the study was a non–significant risk device study.
Additional Contributions: BodyOrnament Company/Blue Mountain Steel, Inc, donated barbells and piercing supplies; Anatometal, Inc, designed and manufactured the magnet-containing tongue barbells; and Pride Mobility, Inc, donated the powered wheelchair.